Figure 8.
Tauroursodeoxycholic acid leads to a reduction of acute graft-versus-host disease. A model, in which this positive effect is achieved by two distinct mechanisms: enhancing the viability during exposure to pro-inflammatory cytokines and reduction of antigen presentation in the intestine with a consequent decrease in apoptosis.
